Impact of abiraterone acetate plus prednisone or enzalutamide on fatigue and cognition in patients with metastatic castration-resistant prostate cancer: initial results from the ob...

por Thiery-Vuillemin, Antoine, Hvid Poulsen, Mads, Lagneau, Edouard, Ploussard, Guillaume, Birtle, Alison, Dourthe, Louis-Marie, Beal-Ardisson, Dominique, Pintus, Elias, Trepiakas, Redas, Antoni, Laurent, Lukac, Martin, Van Sanden, Suzy, Pissart, Geneviève, Reid, Alison
Publicado 2018

Assessment of the Safety of Glucocorticoid Regimens in Combination With Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer: A Randomized, Open-label Phase 2 St...

por Attard, Gerhardt, Merseburger, Axel S, Arlt, Wiebke, Sternberg, Cora N, Feyerabend, Susan, Berruti, Alfredo, Joniau, Steven, Géczi, Lajos, Lefresne, Florence, Lahaye, Marjolein, Shelby, Florence Nave, Pissart, Geneviève, Chua, Sue, Jones, Robert J, Tombal, Bertrand
Publicado 2019

Abiraterone acetate plus prednisone for the Management of Metastatic Castration-Resistant Prostate Cancer (mCRPC) without prior use of chemotherapy: report from a large, internatio...

por Boegemann, Martin, Khaksar, Sara, Bera, Guillaume, Birtle, Alison, Dopchie, Catherine, Dourthe, Louis-Marie, Everaert, Els, Hatzinger, Martin, Hercher, Dirko, Hilgers, Werner, Matus, Geoffrey, Alvarez, Laura Garcia, Antoni, Laurent, Lukac, Martin, Pissart, Geneviève, Robinson, Paul, Elliott, Tony
Publicado 2019